
MEDICALIP developed MEDIP COVID19 in two weeks based on MEDICALIP’s own AI medical image analysis technology of MEDIP PRO.
The company has developed a technology that can automatically detect, segment, and quantify COVID-19 pneumonia lesions using chest CT images, and distribute it worldwide for free to contribute to resolving the COVID-19 pandemic.